About this trial
To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer
Eligibility criteria
Qualifiers
Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
Age ≥ 18 years
Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy
Ability to understand and willingness to sign written informed consent
Disqualifiers
History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.
Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.
Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.
Trial design
Treatments tested in this trial
- Standard of Care